How does Delsym (dextromethorphan) compare to other cough suppressants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dextromethorphan (Delsym) vs. Other Cough Suppressants

Dextromethorphan (Delsym) is the recommended first-line treatment for dry cough with superior efficacy and safety profile compared to other cough suppressants like codeine or pholcodine, which have greater adverse effects despite similar efficacy. 1

Efficacy Comparison

Dextromethorphan (Delsym)

  • Acts centrally to suppress the cough reflex 1
  • Recommended dosage: 30 mg every 6-8 hours, not exceeding 120 mg in 24 hours 1
  • Available in extended-release formulation (Delsym) providing 12-hour cough relief 2
  • Shown to reduce cough frequency by 21-25.5% compared to placebo in children 3
  • Non-sedating opiate derivative with proven cough suppression in meta-analysis 4
  • Maximum cough reflex suppression occurs at 60 mg with prolonged effect 4

Other Cough Suppressants

  1. Codeine/Pholcodine

    • No greater efficacy than dextromethorphan 4, 1
    • Much higher adverse side effect profile 4, 1
    • Not recommended due to safety concerns 4, 1
  2. Menthol

    • Suppresses cough reflex when inhaled 4
    • Effect is acute and short-lived 4
    • Available as menthol crystals or proprietary capsules 4
  3. Sedating Antihistamines

    • First-generation antihistamines suppress cough but cause drowsiness 4
    • May be suitable specifically for nocturnal cough 4
    • Newer non-sedating antihistamines (like bilastine) combined with dextromethorphan show efficacy with less drowsiness 5

Safety Considerations

  • Dextromethorphan is generally well-tolerated at recommended doses 3
  • Care must be taken with higher doses, especially with combined preparations containing other ingredients like paracetamol 4
  • Overdose can be serious, particularly in children - a case report showed life-threatening symptoms with blood concentration exceeding 100 ng/mL 6
  • The extended-release polistirex formulation (Delsym) has a duration of action 2-3 times longer than standard formulations 6
  • Contains sodium metabisulfite, which may cause allergic-type reactions in sensitive individuals 2

Clinical Application

For dry cough management:

  1. First-line: Dextromethorphan 30 mg every 6-8 hours (or extended-release formulation for 12-hour coverage) 4, 1, 2
  2. Alternative for nighttime cough: Sedating antihistamines if sleep disruption is a major concern 4
  3. Adjunctive therapy: Menthol for short-term relief 4
  4. Avoid: Codeine or pholcodine due to poor benefit-risk ratio 4, 1

Special Considerations

  • For productive cough, guaifenesin (200-400 mg every 4 hours) is recommended instead of dextromethorphan 1
  • Simple home remedies like honey and lemon may be beneficial and cost-effective for mild cases 4, 1
  • Voluntary suppression of cough may be sufficient in some cases 4
  • Cough lasting more than 8 weeks requires evaluation for underlying causes 1

Common Pitfalls

  • Using subtherapeutic doses of dextromethorphan (generally recommended OTC doses may be lower than optimal therapeutic doses) 4
  • Failing to recognize that extended-release formulations (Delsym) have different dosing schedules than immediate-release products
  • Using opiate-based cough suppressants when dextromethorphan would provide similar efficacy with fewer side effects 4, 1
  • Treating productive cough with suppressants rather than expectorants 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.